Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Pharmaceutical Affairs Law Amendment Passes Diet
August 5, 2002
- WORLD NEWS IN BRIEF
July 29, 2002
- Health Minister Concerned about Delay in Domestic R&D
July 29, 2002
- Nippon Kayaku Not to Spin Off Non-Pharma Business: Mr Nakamura
July 29, 2002
- NEW PRODUCTS
July 29, 2002
- Tanabe Aims at World-class Performance for Each Division: President Hayama
July 29, 2002
- FY2003 Budget Formation Schedule Confirmed
July 29, 2002
- US Consumers Appreciate Online Healthcare Information: PhRMA Seminar
July 29, 2002
- REGULATORY NEWS IN BRIEF
July 29, 2002
- 15th Interphex Japan
July 29, 2002
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
July 29, 2002
- Nippon Chemiphar to Beef Up Its Generic Business
July 29, 2002
- Asahi Kasei to Look For Lead Compounds with SGX
July 29, 2002
- Promoting GE Use Needs Various Means: Mr Wright of EFPIA
July 29, 2002
- MPC-backed New Foundation Invites Applications for CV Research Grants
July 29, 2002
- Takeda to Expand Lineup of Antidiabetic Drugs
July 29, 2002
- GL on Subarachnoidal Hemorrhages Prepared by Korosho Study Group
July 29, 2002
- Bayer Wants to Keep 2-3% Increase in Adalat Sales
July 29, 2002
- Public Health Research Center Initiates Clinical Study on Breast Cancer
July 29, 2002
- Kuraya Sanseido Aims at Operating Profit Ratio of 2%
July 29, 2002
ページ
Adeno-associated virus (AAV) gene therapies have long been viewed as carrying only a minimal risk of insertional mutagenesis — a…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…